VistaGen Therapeutics
VTGN
VTGN
34 hedge funds and large institutions have $15.7M invested in VistaGen Therapeutics in 2023 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 12 closing their positions.
Holders
34
Holders Change
+1
Holders Change %
+3.03%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
11
Reduced
7
Closed
12
Calls
$4.96M
Puts
$835K
Net Calls
+$4.13M
Net Calls Change
+$4.1M
Top Buyers
Top Sellers
1 |
GCP
1
GSA Capital Partners
London,
United Kingdom
|
$245K |
2 |
2
Millennium Management
New York
|
$88.4K |
3 |
3
Goldman Sachs
New York
|
$0 |
4 |
YIH
4
Y-Intercept (HK)
Hong Kong
|
$0 |
5 |
5
BlackRock
New York
|
$461K |